Utilizing AML primary patient expression data from the Microarray Innovations in Leukemia study [14], we determined that the expression of the E3 ligase FBXO21 is significantly downregulated in AML compared to healthy BM (Fig. 1A). Here, FBXO21 is linked to acute myeloid leukemia.